Celprogen is engaged in the development of therapeutic products on cardiology, oncology, diabetes and neurology. Celprogen was founded in 2002. Celprogen's headquarters is located in Torrance, California, USA 90503.
Celprogen's CEO, Jay Sharma, curre... Celprogen's CEO, Jay Sharma, currently has an approval
rating of 90%. Celprogen's primary competitors are ORIG3N, Medicure & RoosterBio.
There have been no acquisitions found related to Celprogen
Funding data cannot be found related to Celprogen
Recent investment data cannot be found related to Celprogen